MENLO PARK, Calif.,
Nov. 25, 2020 /PRNewswire/
-- Montes Archimedes Acquisition Corp. (Nasdaq: MAACU) (the
"Company") announced that, commencing November 27, 2020, holders of the units sold in
the Company's initial public offering of 41,071,823 units,
completed on October 9, 2020, may
elect to separately trade the shares of Class A common stock and
warrants included in the units. Those units not separated will
continue to trade on the Nasdaq Capital Market ("Nasdaq") under the
symbol "MAACU," and the shares of Class A common stock and warrants
that are separated will trade on Nasdaq under the symbols "MAAC"
and "MAACW," respectively. Holders of units will need to have their
brokers contact Continental Stock Transfer & Trust Company, the
Company's transfer agent, in order to separate the units into
shares of Class A common stock and warrants.
The units were initially offered by the Company in an
underwritten offering. Citigroup Global Markets Inc. and
Jefferies LLC acted as book running managers for the offering.
A registration statement relating to the units and the underlying
securities was declared effective by the Securities and Exchange
Commission (the "SEC") on October 6,
2020.
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy the securities of the Company, nor
shall there be any sale of these securities in any state or
jurisdiction in which such offer, solicitation or sale would be
unlawful prior to registration or qualification under the
securities laws of any such state or jurisdiction. The offering was
made only by means of a prospectus, copies of which may be obtained
from Citigroup Global Markets, c/o Broadridge Financial
Solutions, 1155 Long Island Avenue, Edgewood, New
York 11717, or by telephone at (800) 831-9146, and from
Jefferies LLC, Attention: Equity Syndicate Prospectus Department,
520 Madison Avenue, 2nd Floor, New York, NY 10022, by
telephone at 1-877-821-7388 or by email
at Prospectus_Department@Jefferies.com.
About Montes Archimedes Acquisition Corp.
The Company is a special purpose acquisition company formed for
the purpose of entering into a combination with one or more
businesses. The Company intends to identify a prospective target
company and complete an initial business combination in the health
care industry. Montes Archimedes is sponsored by Patient
Square Capital LLC and led by Chairman, CEO and President, Jim
Momtazee, and Chief Financial Officer, Maria Walker.
Forward-Looking Statements
This press release may include "forward-looking statements"
within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. All statements other than statements of historical fact
included in this press release are forward-looking statements. When
used in this press release, words such as "anticipate," "believe,"
"estimate," "expect," "intend" and similar expressions, as they
relate to us or our management team, identify forward-looking
statements. Such forward-looking statements are based on the
beliefs of management, as well as assumptions made by, and
information currently available to, the Company's management.
Actual results could differ materially from those contemplated by
the forward-looking statements as a result of certain factors
detailed in the Company's filings with the SEC. All subsequent
written or oral forward-looking statements attributable to us or
persons acting on our behalf are qualified in their entirety by
this paragraph. Forward-looking statements are subject to numerous
conditions, many of which are beyond the control of the Company,
including those set forth in the Risk Factors section of the
Company's registration statement and prospectus relating to the
Company's initial public offering filed with the SEC. The Company
undertakes no obligation to update these statements for revisions
or changes after the date of this release, except as required by
law.
View original
content:http://www.prnewswire.com/news-releases/montes-archimedes-acquisition-corp-announces-the-separate-trading-of-its-shares-of-class-a-common-stock-and-warrants-commencing-november-27-2020-301180790.html
SOURCE Montes Archimedes Acquisition Corp.